June 28th, 2023, the first capsule workshop of Humanwell Pharmaceutical Excipients’ Relocation and Expansion Project was officially put into production.

At the end of 2021, Humanwell Pharmaceutical Excipients launched a relocation and expansion project with a total investment of 1 billion yuan. The project is based on the principle of high-starting-point planning, high-standard construction, high-quality management and high-efficiency operation to create an internationalized and digitalized green factory.

The capsule workshop is in strict accordance with the US FDA certification requirements, is domestic first-class and internationally renowned enterprises from design and construction to equipment selection, and follows the global unified quality system, which marks that the empty capsule products of Humanwell Pharmaceutical Excipients fully meets the needs of European and American pharmaceutical companies.

Through intelligent control operation, strict indoor cleaning procedures, quality monitoring, other excellent production processes and conditions, the uniformity and stability of each empty capsule are guaranteed.

About Humanwell Pharmaceutical Excipients
Hubei Humanwell Pharmaceutical Excipients Co., Ltd.is a high-tech branch of Humanwell Healthcare Group, specializing in the production of capsules, and with over 20 years of capsules production experience.

With planned total annual production capacity of 40 billions of empty capsules.
Currently has 16 imported automatic capsule production lines, with an annual production capacity of 15 billions of capsules.